Jochmans Sebastien, Mazerand Sandie, Chelly Jonathan, Pourcine Franck, Sy Oumar, Thieulot-Rolin Nathalie, Ellrodt Olivier, Mercier Des Rochettes Emmanuelle, Michaud Gaël, Serbource-Goguel Jean, Vinsonneau Christophe, Vong Ly Van Phach, Monchi Mehran
Département de Médecine Intensive-Réanimation, GH Sud Ile-de-France, Hôpital de Melun, 270 avenue Marc Jacquet, 77000, Melun, France.
Unité de Recherche Clinique, GH Sud Ile-de-France, Hôpital de Melun, 270 avenue Marc Jacquet, 77000, Melun, France.
Ann Intensive Care. 2020 May 24;10(1):66. doi: 10.1186/s13613-020-00683-7.
Prone position (PP) is highly recommended in moderate-to-severe ARDS. However, the optimal duration of PP sessions remains unclear. We searched to evaluate the time required to obtain the maximum physiological effect, and to search for parameters related to patient survival in PP.
It was a prospective, monocentric, physiological study. We included in the study all prone-positioned patients in our ICU between June 2016 and January 2018. Pulmonary mechanics, data from volumetric capnography and arterial blood gas were recorded before prone positioning, 2 h after proning, before return to a supine position (SP) and 2 h after return to SP. Dynamic parameters were recorded before proning and every 30 min during the session until 24 h. 103 patients (ARDS 95%) were included performing 231 PP sessions with a mean length of 21.5 ± 5 h per session. They presented a significant increase in pH, static compliance and PO/FO with a significant decrease in PCO, P, phase 3 slope of the volumetric capnography, PCO, V/V and ΔP. The beneficial physiological effects continued after 16 h of PP and at least up to 24 h in some patients. The evolution of the respiratory parameters during the first session and also during the pooled sessions did not find any predictor of response to PP, whether before, during or 2 h after the return in SP.
PP sessions should be prolonged at least 24 h and be extended in the event that the PO/FO ratio at 24 h remains below 150, especially since no criteria can predict which patient will benefit or not from it. Trial registration The trial has been registered on 28 June 2016 in ClinicalTrials.gov (NCT02816190) (https://clinicaltrials.gov/ct2/show/NCT02816190?term=propocap&rank=1).
对于中重度急性呼吸窘迫综合征(ARDS),强烈推荐采用俯卧位(PP)。然而,PP治疗的最佳时长仍不明确。我们旨在评估获得最大生理效应所需的时间,并寻找与PP治疗中患者生存相关的参数。
这是一项前瞻性、单中心的生理学研究。我们纳入了2016年6月至2018年1月期间在我们重症监护病房(ICU)接受俯卧位治疗的所有患者。在俯卧位前、俯卧2小时后、恢复仰卧位(SP)前以及恢复SP后2小时记录肺力学、容积二氧化碳描记法数据和动脉血气。在俯卧位前以及治疗期间每30分钟记录一次动态参数,直至24小时。纳入103例患者(95%为ARDS),共进行231次PP治疗,每次治疗平均时长为21.5±5小时。他们的pH值显著升高,静态顺应性和氧合指数(PO/FO)显著升高,而二氧化碳分压(PCO₂)、气道平台压(Pplat)、容积二氧化碳描记法的第3相斜率、呼气末二氧化碳分压(PETCO₂)、死腔量/潮气量(Vd/Vt)和驱动压(ΔP)显著降低。PP治疗16小时后有益的生理效应仍持续存在,部分患者至少持续至24小时。在首次治疗期间以及汇总治疗期间,呼吸参数的变化未发现任何可预测对PP治疗反应的指标,无论是在恢复SP前、恢复过程中还是恢复后2小时。
PP治疗应至少延长至24小时,如果24小时时的PO/FO比值仍低于150,则应进一步延长,特别是因为尚无标准能够预测哪些患者会从PP治疗中获益或不受益。试验注册 该试验于2016年6月28日在ClinicalTrials.gov(NCT02816190)(https://clinicaltrials.gov/ct2/show/NCT02816190?term=propocap&rank=1)注册。